Pancreatic beta cells, which are essential to insulin production, are reduced by 40-60% in patients with type 2 diabetes, and 70-97% in patients with type 1 diabetes. Researchers have long sought ways to achieve beta cell regeneration in people with diabetes. Recent research suggests a combination of GLP-1 agonists and DYRK1A inhibitors may work to increase adult human beta cell proliferation. Read more